Under the condition of high glucose and insulin resistance, the dysregulated transcriptional activity of FoxO1 enhances the biosynthesis of SelP and gluconeogenic enzymes, which results in elevated plasma SelP and selenium levels and further elevated plasma glucose levels (72, 115, 116). The gene discussed is SELP; the disease is Insulin resistance.